Team
Quantitative Immuno-hematology
Thematic areas of research:
Image
To top
Team
LEILA PERIE
Quantitative Immuno-hematology
Our research interest lies in understanding quantitatively how hematopoiesis functions during homeostasis, ageing and infection. To untangle this question, we combine experimental and computational approaches at the single cell level both in mouse and human.
If you like interdisciplinary works, consider joining our team! We are always looking for students and postdocs.
Members
Past members
Image
Key publications
All publications
-
Hematopoiesis in numbersTrends in Immunology
-
Comparing Phylogenetic Approaches to Reconstructing Cell Lineage From Microsatellites With Missing DataIEEE/ACM Transactions on Computational Biology and Bioinformatics
-
-
-
News
All news
-
DNA barcodes to identify groups of cellsA team from Institut Curie and CNRS has developed an open-access software and experimental guide to help researchers analyze cell genealogy. Their study was published in Nature Computational on Monday February the 19th. These results could have numerous applications in cancer research, in particular to identify groups of cells involved in certain mechanisms, such as resistance to treatment.22/02/2024
-
Congratulations to Dr Leïla Perié, winner of an ERC Consolidator GrantOn Thursday November 23, 2023, Dr. Leïla Perié, head of the Quantitative Immuno-hematology team (CNRS UMR168 / Sorbonne Université), was awarded a European Research Council Consolidator Grant. This €2 million grant supports her "Dynamyelo" project, which addresses the mysteries of myeloid cell dynamics during immune responses.04/12/2023
-
Congratulations to Leïla Périé and Antoine Coulon, winners of the CNRS Bronze Medal 2023Two scientists from the Research Center have just been honored by the CNRS. Each year the organization rewards the women and men who have made the greatest contributions to its reputation and progress in research. The 2023 edition once again recognizes the excellence of the researchers working at Institut Curie’s Research Center.04/04/2023
-
Epigenetic treatments: New allies for chemotherapies?Though chemotherapies are effective in some patients, tumour cells may acquire tolerance to these treatments. In other words, cells adapt to chemotherapy so they can survive.04/05/2022